Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 20170280)

1.

Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.

Tamhane M, Chakilam AR, Jayaraj A, Thakkar V, Taft DR.

Drug Dev Ind Pharm. 2010 Mar;36(3):315-22. doi: 10.3109/03639040903154200.

PMID:
20170280
2.

Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.

Nadai M, Kato M, Yoshizumi H, Kimura M, Kurono S, Abe F, Saito H, Hasegawa T.

Life Sci. 2007 Sep 22;81(15):1175-82. Epub 2007 Aug 30.

PMID:
17897683
3.

Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.

Ajavon AD, Bonate PL, Taft DR.

Eur J Pharm Sci. 2010 Jun 14;40(3):209-16. doi: 10.1016/j.ejps.2010.03.014. Epub 2010 Mar 25.

PMID:
20347037
4.

Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.

Statkevich P, Fournier DJ, Sweeney KR.

J Pharmacol Exp Ther. 1993 Jun;265(3):1118-24.

PMID:
8509997
5.

A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.

Tahara H, Kusuhara H, Endou H, Koepsell H, Imaoka T, Fuse E, Sugiyama Y.

J Pharmacol Exp Ther. 2005 Oct;315(1):337-45. Epub 2005 Jul 8.

6.

Renal excretion of emtricitabine I: effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretion.

Nakatani-Freshwater T, Taft DR.

J Pharm Sci. 2008 Dec;97(12):5401-10. doi: 10.1002/jps.21370.

PMID:
18351632
7.

Renal excretion of apricitabine in rats: ex vivo and in vivo studies.

Babayeva M, Cox S, White MP, Taft DR.

Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):141-50. doi: 10.1007/s13318-011-0038-9. Epub 2011 Apr 6.

PMID:
21744041
8.

Characterization of pentamidine excretion in the isolated perfused rat kidney.

Poola NR, Kalis M, Plakogiannis FM, Taft DR.

J Antimicrob Chemother. 2003 Sep;52(3):397-404. Epub 2003 Jul 29.

9.

The effect of probenecid on the renal elimination of cimetidine.

Gisclon LG, Boyd RA, Williams RL, Giacomini KM.

Clin Pharmacol Ther. 1989 Apr;45(4):444-52.

PMID:
2702802
11.

Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1).

Lai Y, Sampson KE, Balogh LM, Brayman TG, Cox SR, Adams WJ, Kumar V, Stevens JC.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):936-44. doi: 10.1124/jpet.110.170753. Epub 2010 Jun 2.

14.

Effects of organic anion, organic cation, and dipeptide transport inhibitors on cefdinir in the isolated perfused rat kidney.

Lepsy CS, Guttendorf RJ, Kugler AR, Smith DE.

Antimicrob Agents Chemother. 2003 Feb;47(2):689-96.

15.

Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.

Damjanov N, Kauffman RS, Spencer-Green GT.

Arthritis Rheum. 2009 May;60(5):1232-41. doi: 10.1002/art.24485. Erratum in: Arthritis Rheum. 2009 Oct;60(10):3071.

16.
17.
18.

Application of the isolated perfused rat kidney model to assess gender effects on drug excretion.

Taft DR, Dontabhaktuni A, Babayeva M, Nakatani-Freshwater T, Savant IA.

Drug Dev Ind Pharm. 2006 Sep;32(8):919-28.

PMID:
16954104
19.

Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.

Aiba T, Sakurai Y, Tsukada S, Koizumi T.

J Pharmacol Exp Ther. 1995 Jan;272(1):94-9.

PMID:
7815370
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk